Publications by authors named "Mamiko Momoki"

Claim this Profile
S
Second-line anti-CD38 monoclonal antibody therapy mitigates the negative impact of functional high-risk status in myeloma patients.
Kazuhito Suzuki, Tadahiro Gunji, Riku Nagao, Masaharu Kawashima, Hideki Uryu, Mamiko Momoki

Int J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis.
Hirofumi Yamauchi, Mamiko Momoki, Yutaro Kamiyama, Tadahiro Gunji, Hiroki Yokoyama

Intern Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of post-transplantation therapy to sustained MRD negativity in multiple myeloma: a retrospective analysis.
Kazuhito Suzuki, Tadahiro Gunji, Masaharu Kawashima, Hideki Uryu, Riku Nagao, Mamiko Momoki

Int J Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the role of insulin-like growth factor binding protein-1 in identifying idiopathic multicentric Castleman's disease types: Implications for the mTOR signaling pathway.
Remi Sumiyoshi, Tomohiro Koga, Shoichi Fukui, Kaori Furukawa, Mamiko Momoki

Clin Immunol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysis.
Kaito Harada, Makoto Onizuka, Takehiko Mori, Hiroaki Shimizu, Sachiko Seo, Mamiko Momoki

Int J Infect Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
Hiroyuki Ueda, Hideaki Kuno, Daisuke Takahashi, Ai Katsuma, Ai Kimura, Mamiko Momoki

CEN Case Rep· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
Riku Nagao, Rika Hosoba, Yuichi Yahagi, Tadahiro Gunji, Hideki Uryu, Mamiko Momoki

Rinsho Ketsueki· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful treatment with preceding low-intensity chemotherapy in a primary mediastinal large B cell lymphoma patient diagnosed at 11 weeks of pregnancy].
Daiki Hattori, Yuichi Yahagi, Hideki Uryu, Rika Hosoba, Mamiko Momoki

Rinsho Ketsueki· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis